Prothena reported 11.96M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 136.21M 2.97M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Exelixis EXEL:US $ 101.56M 3.06M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Macrogenics MGNX:US $ 17.16M 1.93M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Prothena PRTA:US 11.96M 923K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Xoma XOMA:US $ 4.26M 328K
YTE INCY:US $ 190.7M 21.84M